SCHEMBL2031002

SCHEMBL2031002

C=C(C)C(=O)OCCCOc1ccc(C(=O)O)cc1

nearest known ligand 0.91

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.91
POLB P06746 1/20 0.91
APEX1 P27695 1/20 0.91
TDP1 Q9NUW8 1/20 0.91
PLA2G4B P0C869 5/20 0.59
TSHR P16473 2/20 0.56
TP53 P04637 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.55
ALDH1A1 P00352 1/20 0.55
PKM P14618 1/20 0.54
MAPK1 P28482 2/20 0.54
USP2 O75604 1/20 0.54
ALOX15 P16050 1/20 0.54
HSD17B10 Q99714 1/20 0.54
RARB P10826 4/20 0.52
PLA2G4A P47712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11467186 0.97 HTT (0.97) HTTPOLBAPEX1TDP1PLA2G4B
SCHEMBL2034725 0.97 HTT (0.97) HTTPOLBAPEX1TDP1PLA2G4B
SCHEMBL9952684 0.95 HTT (1.00) HTTPOLBAPEX1TDP1PLA2G4B
SCHEMBL10428187 0.95 HTT (1.00) HTTPOLBAPEX1TDP1PLA2G4B
SCHEMBL8678901 0.95 HTT (1.00) HTTPOLBAPEX1TDP1PLA2G4B
SCHEMBL8682933 0.95 HTT (1.00) HTTPOLBAPEX1TDP1PLA2G4B
SCHEMBL1309117 0.95 HTT (1.00) HTTPOLBAPEX1TDP1PLA2G4B
SCHEMBL10428461 0.95 HTT (1.00) HTTPOLBAPEX1TDP1PLA2G4B
SCHEMBL8962574 0.95 HTT (1.00) HTTPOLBAPEX1TDP1PLA2G4B
Hydrochloric Acid SCHEMBL6450158 0.94 HTT (0.97) HTTPOLBAPEX1TDP1PLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4791042-B2 2011-10-12 JP claimed
EP-1401562-B1 PROCESS FOR THE FORMATION OF EMULSIONS SYNGENTA LTD (GB) 2008-10-08 EP claimed
US-7199185-B2 Use of reactive polymeric surfactants in the formation of emulsions SYNGENTA LIMITED (GB) 2007-04-03 US claimed
EP-1569512-B1 PARTICULATE SUSPENSIONS SYNGENTA LTD (GB) 2007-02-28 EP claimed
US-20060116290-A1 Particulate suspensions SYNGENTA CROP PROTECTION, INC. 2006-06-01 US claimed
EP-1569512-A2 PARTICULATE SUSPENSIONS Syngenta Limited (GB) 2005-09-07 EP claimed
US-20040197357-A1 Use of reactive polymeric surfactants in the formation of emulsions SYNGENTA LIMITED (GB) 2004-10-07 US claimed
WO-2004052099-A2 PARTICULATE SUSPENSIONS SYNGENTA LIMITED (GB) 2004-06-24 WO claimed
EP-1401562-A2 USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS Syngenta Limited (GB) 2004-03-31 EP claimed
WO-2002100525-A2 USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS SYNGENTA LIMITED (GB) 2002-12-19 WO claimed
CN-109153857-B Polarizing layer forming composition 日产化学株式会社 2022-04-26 CN disclosed
CN-109154685-B Alignment layer forming composition 日产化学株式会社 2022-04-19 CN disclosed
CN-109476926-B Polymer composition 日产化学株式会社 2022-03-04 CN disclosed
CN-107615148-B Liquid crystal aligning agent for photo-alignment, alignment material and phase difference material 日产化学工业株式会社 2021-05-25 CN disclosed
EP-3299879-B1 LIQUID CRYSTAL ALIGNING AGENT FOR PHOTO-ALIGNMENT, ALIGNING MATERIAL AND RETARDATION MATERIAL NISSAN CHEMICAL CORP (JP) 2020-09-09 EP disclosed
WO-1991019773-A1 FLUORINE-CONTAINING ACRYLATE AND METHACRYLATE SIDE-CHAIN LIQUID CRYSTAL MONOMERS AND POLYMERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-12-26 WO disclosed
US-4925589-A ADDITION ACRYLIC TYPE POLYMER HOFFMANN-LA ROCHE INC. (US) 1990-05-15 US disclosed
EP-0007574-B1 LIQUID-CRYSTALLINE POLYMERIC PHASE WITH A CHOLESTERIC STRUCTURE, METHOD FOR ITS PREPARATION AND ITS USE BASF Aktiengesellschaft (DE) 1983-05-25 EP disclosed
US-4293435-A ACRYLATE POLYMERS BASF AKTIENGESELLSCHAFT (DE) 1981-10-06 US disclosed
EP-0007574-A1 Liquid-crystalline polymeric phase with a cholesteric structure, method for its preparation and its use BASF Aktiengesellschaft (DE) 1980-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040197357-A1 Use of reactive polymeric surfactants in the formation of emulsions PHOSPHO1, APOB, LIPA HTT 622/4885POLB 143/4885APEX1 3018/4885
US-20060116290-A1 Particulate suspensions PFAS, VCL, JMJD7 HTT 1259/4885POLB 901/4885APEX1 1537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.